Enhanceing Antitumor Effect of Adriamycin Nanoparticle - Lipiodol Emulsion by Pretreating Tumor Cells with Diethyldithiocarbamate

  • Dao Cheng Wu
  • , Ming Xi Wan
  • , Yong Feng Du
  • , Jian Mo
  • , Hong Wu

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The antitumor effect of adriamycin nanoparticle-lipiodol emulsion combined with Diethyldithiocarbamate (DDC) was studied. SD rats with carcinoma were divided to six groups and respectively treated by delivering saline, adriamycin, adriamycin nanoparticle-lipiodol emulsion, adriamycin liposome- lipiodol emulsion, DDC and adriamycin nanoparticle-lipiodol emulsion, DDC and adriamycin Liposome- lipiodol emulsion. The volume of every tumor in rats, tumors growth rate(G%) and life prolong rate PL% in six groups were determined. It was found the value of the IC50(ug/ml) of adriamycin was reduced from 18.40 to 0.74 for the resistant cells SGC7901/CVR, and from 4.00 to 0.32 for the sensitive cells SGC7901/WT by pretreating the tumor cells with DDC. The tumors growth rate(G%) and life prolong rate PL% in rats increased significantly(P<0.05) in the groups DDC pretreated than adriamycin nanoparticle-lipiodol or adriamycin Liposome-lipiodol emulsion groups. It is conformed the antitumor effect of adriamycin can be enhanced by inhibiting the superoxide dismutase (SOD) in tumor cells with DDC.

Original languageEnglish
Pages (from-to)181-184
Number of pages4
JournalInternational Journal of Nonlinear Sciences and Numerical Simulation
Volume3
Issue number3-4
DOIs
StatePublished - 2002

Keywords

  • Adriamycin
  • Diethyldithiocarbamate
  • Intervention
  • Nanoparticle
  • Superoxide

Fingerprint

Dive into the research topics of 'Enhanceing Antitumor Effect of Adriamycin Nanoparticle - Lipiodol Emulsion by Pretreating Tumor Cells with Diethyldithiocarbamate'. Together they form a unique fingerprint.

Cite this